CDR Seminars
The CDR Neuroscience Seminar Series brings renowned scientist from institutions across the country and the world to present their work and provide a platform for advanced scientific dialogue on topics related to the interests of CDR scientists. These seminars, open to the scientific community from area institutions, are regularly organized to provide an opportunity for collaboration in an intellectually stimulating environment.
Due to Covid-19, scheduled seminars from 2020 and 2021 have been rescheduled to 2022.
Upcoming 2022 Seminars
In search of an explanation of Alzheimer Disease
George Perry, PhD
The University of Texas at San Antonio, San Antonio, TX
October 6th, 2022
Interaction of microglia with amyloid plaques
Frederick Maxfield, PhD
Weill Cornell Medical College, New York, NY
November 10th, 2022
Amyloid beta-peptide, brain lipid peroxidation and Alzheimer disease: Focus on the intersection of HNE-bound proteins, glucose dysmetabolism, altered proteostasis network, and neuronal death
D.Allan Butterfield, PhD
University of Kentucky, Lexington, KY
December 15th, 2022
Microglial TREM2 interactome in Alzheimer’s disease.
Tae-Wan Kim
Columbia University, New York, NY
January 19th, 2023
ApoE4 and Alzheimer's Disease: Molecular Mechanisms and Therapeutic Strategies
Yadong Huang, PhD
UCSF Gladstone Institute, San Francisco, CA
February 2nd, 2023
Exploring the roles of microglia in the healthy and Alzheimer's disease brain
Kim Green, PhD
University of California, Irvine, CA
February 16th, 2023
Mitochondrial Psychobiology
Martin Picard, PhD
Columbia University Irving Medical Center, New York, NY
March 2nd, 2023
A Selective Eater that Protects Brain
Zhenyu Yue, PhD
Icahn School of Medicine at Mount Sinai, New York, NY
March 16th, 2023
2021 Seminars
Novel Mechanisms of epigenetic regulation in stress and main CNS diseases: Crosstalk between mitochondria and cell nuclei
Carla Nasca, PhD
The Rockefeller University, New York, NY
April 26, 2021
2020 Seminars
The Senescent Synapse: from the Membrane to the Nucleus
Thomas Foster, PhD
University of Florid, Gainesville, Florida
January 23, 2020
2019 Seminars
The role of IGF-2 in memory and neuropsychiatric diseases
Cristina Alberini, PhD
New York University, New York, NY
January 10, 2019
Big Data Analysis and Genetic Liability to Neuropsychiatric Disease
Panagiotis Roussos, MD, PhD
Icahn School Of Medicine at Mount Sinai, New York, NY
January 17, 2019
Dissecting neural mechanisms of evoked and Spontaneous pain: An multidisciplinary approach
Zhe Chen, PhD
New York University, New York, NY
January 31, 2019
What do reactive astrocytes do ?
Shane Liddelow, PhD
New York University, New York, NY
February 28, 2019
Perspectives on Treatment of Neurologic Lysosomal Storage Diseases
Kostantin Dobrenis, PhD
Albert Einstein College of Medicine, Bronx, NY
March 21, 2019
Pathologic tau protein metabolism in ALS
Michael Strong, MD
Schulich School of Medicine and Dentistry, Ontario, Canada
May 2, 2019
Neuroprotective Effects of Androgen Metabolites-are they the basis for sex differences in the incidence of Alzheimer's Disease?
Neil J MacLusky, PhD
University of Guelph, Ontario, Canada
May 30, 2019
Early-life environmental factors regulating the serotonergic system - Impact on the dopaminergic system and motivation
Catia Teixeira, PhD
Nathan S.Kline Institute, Orangeburg, New York
September 10, 2019>
Presenilin and APP in familial Alzheimer's disease
Jie Shen, PhD
Harvard Medical School, Boston, MA
September 19, 2019
Deconstructing the molecular networks of the aging brain
Phillip De Jager, MD, PhD
Columbia University Medical Center, NY
September 26, 2019
Systems biology of rare Neurological disorders
Victor Faundez, MD, PhD
Emory University, Atlanta, GA
October 3, 2019
Experimental preclinical validation of targets derived from the the NIA accelerating medicines partnership-Alzheimer's Disease Project
Michelle Ehrlich, MD
Ichan School of Medicine Mount Sinai, New York, NY
October 31, 2019
Synaptic and dendritic mechanisms of brain dysfunction in cognitive aging and Alzheimer's disease
Daniel Nicholson, PhD
Rush University, Chicago, IL
November 21, 2019
2018 Seminars
Pathological consequences of p75 neurotrophin receptor expression in the brain
Khalil Saadipor, PhD
New York University, New York, NY
January 18, 2018
Rearranging the puzzle: A new view on Alzheimer’s disease pathogenesis
Arancio Ottavio, MD
Columbia University Irving Medical Center, New York, NY
February 22, 2018
Hippocampal CA1 circuit heterogeneity through space and time
Arjun Masurkar, MD, PhD
New York University, New York, NY
April 5, 2018
Circuit Mechanisms underlying plasticity of Hippocampal representations
Jayeeta Basu, PhD
New York University, New York, NY
April 26, 2018
The aging suppressor and cognitive enhancer klotho: A novel therapeutic target for neurodegenerative diseases
Carmela Abraham, PhD
Boston University School of Medicine, Boston, MA
May 24, 2018
Early and persistent effects of Parkinson's Disease-linked LRRK2-G2019S mutation on stiatal synaptic function and plasticity
George Huntley, PhD
Icahn School of Medicine at Mount Sinai, New York, NY
May 31, 2018
New Insights on Alzheimer's Disease: Lessons from Carmela Abraham Aβ catabolism
Javier Pacheco-Qunito, PhD
Biomedical Research Institute of New Jersey, Morristown, NJ
June 21, 2018
Axonal Transport and Autophagy-Lysosomal Regulation in Alzheimer's Disease
Qian Cai MD, PhD
Rutgers, The State University of New Jersey, Piscataway, NJ
September 20, 2018
Targeting TDP-43 Splicing Repression for Neurodegenerative Diseas
Philip Wong, PhD
John Hopkins School of Medicine, Baltimore, MD
October 18, 2018
Skin misfolded proteins and neurodegenerative diseases
Wenquan Zou, MD, PhD
Case Western Reserve University School of Medicine, Cleveland, OH
October 25, 2018
Neuroprotective Effects of Androgen Metabolites -are they the basis for sex differences in the incidence of Alzheimer’s Disease?
Neil MacLusky, PhD
University of Guelph, Ontario, Canada
November 15, 2018
2017 Seminars
Cholinergic Control of Fear Behaviors and Fear Memories Engrams
Lorna Role, PhD
Stony Brook University, Stony Brook, NY
January 12, 2017
Regional Vulnerability as a Key to Alzheimer’s Disease & Aging
Scott Small, MD
Columbia University, NreYork, NY
January 19, 2017
Compartmental organization of the Basal forebrain cholinergic system: Anatomy to function and Dysfunction
Laszlo Zaborsky, PhD
Rutgers, The State University of New Jersey, Newark, NJ
February 16, 2017
Apoliprotein E and Alzheimer’s Disease:
Multitude of Biological Effects and Potential for New Therapeutic Approaches
Martin Sadowski, MD, PhD
New York University, New York, NY
March 16, 2017
BAG3and RAB3GAP1/2: Linking Autophagy Regulation to Neuronal Disease
Christian Behl, PhD
Johannes Gutenberg University of Mainz, Mainz, Germany
April 13, 2017
Alzheimer’s disease mimics: common and under-appreciated causes of dementia
Peter Nelson, MD, PhD
University of Kentucky College of Medicine, Lexington, KY
April 24, 2017
Neural dynamics and the structure of cognition
Andre Fenton, PhD
New York University, New York, NY
May 4, 2017
Role of endolysosomes in pathogenesis of HIV-1 associated neurocognitive disorders and
Alzheimer’s disease
Jonathan D. Geiger, PhD
University of Noth Dakota, Grand Forks, ND
May 25, 2017
Dissecting episodic memory circuits and implications for the aging brain
Michael Yassa, PhD
University of California Irvine, Irvine, CA
May 29, 2017
Role of Dyrk1A in Tau Pathogenesis
Fei Liu, PhD
New York State Institute for Basic Research, Staten Island, NY
September 7, 2017
Recent progress in microglia and exosome mediated progression of Alzheimer's disease
Tsuneya Ikezu, MD, PhD
Boston University School of Medicine, Boston, MA
October 19, 2017
Lysosme function, dysfunction and neurodegenerative disease
Shawn Ferguson, PhD
Yale University School of Medicine, New Haven, CT
November 16, 2017
Epileptic activity in Alzheimer's Disease: Causes and Clinical Relevance
Keith Vossel, MD
University of Minnesota, Minneapolis, MN
November 30, 2017
Click here to view the Seminar Series Archives